Metro Healthcare Indonesia Tbk. vs Trimegah Karya Pratama Tbk. — how do they compare? Metro Healthcare Indonesia Tbk. trades at Rp426 (market cap 14.23T, 48.2K 24h volume), while Trimegah Karya Pratama Tbk. trades at Rp137 (market cap 272.02B, 10.56M 24h volume). The key difference: Metro Healthcare Indonesia Tbk. is far larger — about 52.3× Trimegah Karya Pratama Tbk.'s market cap, and Trimegah Karya Pratama Tbk. is more actively traded (10.56M versus 48.2K). Which is the better fit depends on your goals.
| CARE | UVCR | |
|---|---|---|
Market Cap | 14.23T | 272.02B |
Volume | 48.2K | 10.56M |
Lot | 482 | 105.62K |
Turnover | 20.61M | 1.45B |
Average Price | 427.65 | 137.16 |
Value | 20.61M | 1.45B |
Indicative Equilibrium Price | 428 | 137 |
Indicative Equilibrium Volume | 400 | 8.03K |
Trailing returns across standard periods
Latest headlines on both assets
PT Metro Healthcare Indonesia Tbk (the “Company”) was established under the name PT Aruna Anjaya Perkasa, based on Notarial Deed No. 67 dated October 07, 2015 of Humberg Lie, S.H., S.E., M.Kn notary in Jakarta. The Company started its commercial operations in 2016 .
Read more on CARE →PT Trimegah Karya Pratama Tbk (the Company) was established based on Notarial Deed No. 21 dated July 7, 2017 of Netty Maria Machdar, S.H. The Company started its commercial operations in 2018. The Company’s immediate parent company is PT Trimegah Sumber Mas, which was established and domiciled in Indonesia, while its ultimate Parent Company is PT Hutama Mulia Rajawali, which was established and domiciled in Indonesia.
Read more on UVCR →